We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.78B
AUM Growth
-$185M
Cap. Flow
-$20.5M
Cap. Flow %
-0.74%
Top 10 Hldgs %
20.31%
Holding
3,133
New
26
Increased
312
Reduced
483
Closed
54

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$3.61M
2
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$3.51M
3
SRLN icon
State Street Blackstone Senior Loan ETF
SRLN
+$2.84M
4
PWR icon
Quanta Services
PWR
+$2.44M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.13M

Top Sells

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$4.58M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$4.54M
3
CONE
CyrusOne Inc Common Stock
CONE
+$4.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.09M
5
IVE icon
iShares S&P 500 Value ETF
IVE
+$3.23M

Sector Composition

Rank Sector Weight
1 Technology 18.27%
2 Consumer Discretionary 10.26%
3 Financials 9.82%
4 Industrials 9.34%
5 Healthcare 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOFV
2951
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$5K ﹤0.01%
196
– –
KALA icon
2952
KALA BIO
KALA
$17.2M
$5K ﹤0.01%
1
– –
KRRO icon
2953
Korro Bio
KRRO
$194M
$5K ﹤0.01%
43
– –
MEC icon
2954
Mayville Engineering Co
MEC
$601M
$5K ﹤0.01%
556
– –
LITS
2955
Lite Strategy Inc
LITS
$30.6M
$5K ﹤0.01%
383
– –
MIRM icon
2956
Mirum Pharmaceuticals
MIRM
$6.03B
$5K ﹤0.01%
225
– –
NGNE icon
2957
Neurogene
NGNE
$727M
$5K ﹤0.01%
131
– –
PRLD icon
2958
Prelude Therapeutics
PRLD
$425M
$5K ﹤0.01%
769
– –
RQI icon
2959
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
$5K ﹤0.01%
300
-112
-27% -$1.81K
TISI icon
2960
Team
TISI
$101M
$5K ﹤0.01%
241
– –
CLYM
2961
Climb Bio
CLYM
$846M
$5K ﹤0.01%
541
– –
SEEL
2962
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$5K ﹤0.01%
2
– –
ONCT
2963
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5K ﹤0.01%
174
– –
HARP
2964
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$5K ﹤0.01%
110
– –
TIG
2965
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$5K ﹤0.01%
1,026
– –
ATNX
2966
DELISTED
Athenex, Inc. Common Stock
ATNX
$5K ﹤0.01%
300
– –
MBII
2967
DELISTED
Marrone Bio Innovations, Inc.
MBII
$5K ﹤0.01%
4,928
– –
REV
2968
DELISTED
Revlon, Inc.
REV
$5K ﹤0.01%
576
– –
ARCC icon
2969
Ares Capital
ARCC
$14.5B
$4K ﹤0.01%
213
– –
ARES icon
2970
Ares Management
ARES
$32.8B
$4K ﹤0.01%
52
+1
+2% +$77
ATER icon
2971
Aterian
ATER
$5.22M
$4K ﹤0.01%
129
– –
BDTX icon
2972
Black Diamond Therapeutics
BDTX
$117M
$4K ﹤0.01%
1,541
– –
BUYZ icon
2973
Franklin Disruptive Commerce ETF
BUYZ
$5.46M
$4K ﹤0.01%
156
– –
BYSI icon
2974
BeyondSpring
BYSI
$37.4M
$4K ﹤0.01%
1,774
– –
CVRX icon
2975
CVRx
CVRX
$76.5M
$4K ﹤0.01%
623
– –
117 118
119
120 121

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.2B AUM 32.2% 1-Year Est. Return

Ameritas Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Ameritas Investment Partners held 3,133 positions worth $2.78B, down 6.2% from $2.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 2.6%. Ameritas Investment Partners opened 26 new positions and exited 54, leaving the 3,133-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ameritas Investment Partners's largest Q1 2022 buy was Bank of America Series L: 2,589 shares worth $3.4M.
  • Ameritas Investment Partners added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2022, an estimated $3.61M increase.
  • Ameritas Investment Partners's biggest Q1 2022 reduction was Molina Healthcare, cutting an estimated $4.58M.
  • Ameritas Investment Partners fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $4.1M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.78B portfolio in Q1 2022.
  • Ameritas Investment Partners opened 26 new positions and closed 54 in Q1 2022.
  • Ameritas Investment Partners's portfolio value fell 6.2% quarter-over-quarter to $2.78B.

Based on Ameritas Investment Partners's 13F filing for Q1 2022, filed 13 May 2022.